Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2018-10-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于公司及子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding government subsidies received by the company and its subsidiaries during the third quarter of 2018. It details the amounts, sources, accounting treatment, and expected impact on profits. The document is a formal disclosure of government grants and their accounting implications, not a full financial report or audit report. It does not contain comprehensive financial statements or detailed management analysis, nor is it a regulatory certification or voting result. It is a regulatory announcement about government subsidies affecting financial results, which fits best under the category of Regulatory Filings (RNS) as it is a specific compliance disclosure that does not fit other categories like Annual Report, Interim Report, or Earnings Release.
2018-10-24 Chinese
独立董事关于第四届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Guangzhou Yangpu Medical Technology Co., Ltd. regarding matters discussed at the 15th meeting of the 4th Board of Directors. It specifically addresses a change in accounting policy in accordance with regulatory guidelines and confirms compliance with relevant laws and company articles. The document is a formal opinion related to board meeting matters rather than a full audit report or annual report. It does not contain financial statements or detailed audit results but is a governance-related document reflecting board oversight and compliance. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board opinions, not a full report or announcement of voting results.
2018-10-24 Chinese
关于召开2018年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2018 second extraordinary general meeting of shareholders for Guangzhou Yangpu Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), registration details, agenda items (notably the proposal to renew the appointment of the 2018 audit firm), and proxy forms. The document does not contain any financial statements or results but is clearly an announcement to shareholders about the meeting and how to participate and vote. It is not a report itself but a notification about the meeting and voting process. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2018-10-24 Chinese
关于全资子公司取得医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding its wholly-owned subsidiary obtaining a medical device production license. It includes details about the license, issuing authority, and implications for the company. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no earnings data, and no regulatory certifications or attestations. The document is a regulatory announcement about a business development event. It is short (934 characters) and serves as a formal disclosure to investors. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-10-18 Chinese
2018年三季度业绩预告
Earnings Release Classification · 95% confidence The document is a 2018 third quarter earnings forecast (业绩预告) for Guangzhou Yangpu Medical Technology Co., Ltd. It provides estimated net profit figures for the first nine months and the third quarter of 2018 compared to the prior year. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the 2018 third quarter financial report. The document is short (1061 characters) and serves as a preliminary earnings guidance rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. 9M 2018
2018-10-12 Chinese
关于全资子公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Guangzhou Yangpu Medical Technology Co., Ltd. about its wholly-owned subsidiary obtaining a medical device registration certificate issued by the Guangdong Food and Drug Administration. It describes the product (PACS system), its registration details, and potential market impact. The document is brief (1155 characters), contains no financial statements or detailed financial data, and is primarily an official announcement of a regulatory approval related to product registration. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report being published or attached. The content is a regulatory announcement about a product registration certificate, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-09-25 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.